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STATE-OF-THE-ART AND OBJECTIVES
In many cases, access to biological samples is 
needed for molecular analyses. Biopsies or other 
minimally-invasive sampling techniques, in the context 
of virtual autopsy (virtopsy), would reduce risk and 
improve societal acceptance when compared with 
traditional autopsies.
We propose a study that compares and contrasts 
virtopsy with traditional autopsy, using large study 
groups based on four different levels of information: 
Macroscopic; Microscopic; Medical imaging; and 
Molecular phenotypes. This proposal includes the 
development of a machine learning enhanced virtual 
biobank to understand the process of diseases, and to 
evaluate clinical diagnosis and treatment. This virtual 
biobank, enhanced by machine learning and knowledge 
extraction approaches, will be composed of a unique 
collection of non-invasively generated autopsy images 
(e.g., X-ray, computerized tomography, magnetic 
resonance imaging, ultrasound) and digital pathology 
imaging data of corresponding biological samples.
Based on this vast resource, we will experimentally 
design, develop, test and evaluate machine learning 
algorithms that can self-learn from, as well as make 
predictions (based on the virtual biobank data). 
These ambitious studies will help us go beyond 
the state-of-the-art to demonstrate to what extent 
machine learning can enhance medical expertise, so as 
to understand the process of diseases and to evaluate 
both clinical diagnosis and treatment.
The algorithms will make data-driven predictions 
or decisions, by building a model from sample inputs; a 
variety of subject data was used. We will use the same 
machine learning approach developed by a research 
group at the Medical University of Graz.1 They are 
world-leading experts in this field with long-standing 
experience in the application domain, health generally, 
pathology and metabolomics2 in particular.
This strategy will allow achievement of results that 
include the use of fewer images when compared with 
conventional machine learning (e.g., deep learning 
approaches), and so helps to alleviate some major 
issues one would expect for this type of study set-up. 
In the application of virtopsy we do not have access to 
many cases, (i.e., sample-size is small, and not the large 
numbers in the thousands to millions which are usually 
necessary), and so consequently we need algorithms 
which are able to self-learn (with only a few examples), 
in the same way humans do. The chosen approach 
of interactive machine learning is an inventive way to 
overcome this problem. The intention is to utilize this 
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method of smart injective machine learning. It is not 
a black box method, which demands the input of a 
massive amount of data. Instead, expert knowledge 
is fed directly into the algorithmic loop.1 This is an 
ingenious method to deal with standard limitations. 
The necessity of large amounts of data/sample-size 
and cases will always be a limitation for conventional 
machine learning. Our technique will have a unique 
resource to drive the project and achieve our anticipated 
results.
Regarding virtual microscopy, digital pathology 
now provides an entirely innovative technique to 
analyze image data from tissues. We propose a study 
that conducts a systematic comparison between the 
morphology of tissue (as seen by digital pathology) and 
medical images such as magnetic resonance imaging 
(MRI).
In addition, pathologists will provide images 
using a medical care standard digital camera for 
macroscopic documentation and analysis. This image 
will be compared with corresponding medical images, 
as different levels of imaging information add to the 
originality of this study.
Finally, we propose to include nuclear mass 
resonance (NMR) spectroscopy in the active research 
of this study. This adds to the originality and scientific 
aspect as it involves a new level of information 
regarding metabolic status and morphology of tissue. 
Consequently, focus is not only on explaining disease 
biology, but it is also developing machine learning 
algorithms that provide image analysis – currently there 
is a lack of literature on large-scale programmes that 
compare MRI images with both NMR and microscopic 
images.
NMR will enable us to obtain the metabolomic 
profi le, as the metabolome provides detai led 
information about the chemical composition of the 
tissue. For NMR metabolomics, it is essentially the same 
principle as for MRI, but the read-out of the signal is 
different. This is scientifically challenging but relevant, 
as we can then compare MRI data with chemical 
composition of tissue investigated. In addition, we will 
compare this data with histological and macroscopic 
data. There has been no current literature to date 
demonstrating that this has been undertaken in such 
a coordinated approach as set out in our proposal.
Ideally, for this type of image analysis study, 
we intend to include many additional datasets from 
autopsies performed rapidly (~3 hours) after clinical 
death. This is important because virtopsy must be 
compared with traditional autopsy whilst avoiding 
autolysis. The proposed virtual biobank will be used to 
train algorithms to cope with effects due to autolysis and 
other post-mortem effects. This is also of huge relevance 
to forensic medicine. By performing autopsies in as 
early as 3 hours after clinical death, we are managing a 
more feasible situation when compared with secondary 
phenomena due to autolysis. As a result, we will 
collect better material for molecular studies, and this 
is cutting-edge research with the generation of new 
knowledge in the scientific approach.
Furthermore, accessing the affected organs and 
tissues by traditional autopsy provides an opportunity 
for molecular analyses, such as metabolomics by using 
NMR spectroscopy. As discussed, the innovative aspect 
we will introduce to this study is to compare virtopsy 
with traditional autopsy using four different levels of 
data information:
(1) Macroscopic appearance (viewed by eye in 
traditional autopsy using digital photography);
(2) Microscopic appearance (examined by microscope 
in digital pathology);
(3) Medical imaging appearance (e.g., seen by MRI, 
ultrasonography, etc.); and
(4) Molecular phenotypes (e.g., by NMR-based 
metabolomics).
In brief, the main objective is to demonstrate that 
it is possible to create a self-learning system, which will 
assist pathologists and physicians in diagnosing certain 
medical conditions from digital data. This information 
technology (IT) learning approach is a major objective of 
the proposal. We will create an IT-based methodology 
that provides an innovative technique to perform 
autopsies. This includes all other issues with machine 
learning to facilitate physicians to determine the 
correct diagnosis; it revolutionizes the method of 
performing autopsies.
CORE SCIENTIFIC APPROACH
The core scientific approach is the way in which 
we analyze imaging data and how we compare the MRI 
data with morphology or metabolic status. When we 
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use the power of machine learning to analyze imaging 
data, it is very similar in pathology versus radiology 
since the approaches are quite similar. However as 
discussed earlier, a conventional machine learning 
approach requires many thousands of datasets. 
Additionally, such a study requires exceptionally 
detailed annotation to achieve a particular goal; 
this is a valid prerequisite that one may expect to 
be unquestionable and leading to a great result. 
The limited number of datasets will constantly be an 
issue in any autopsy study, whether it is pathology 
or forensic medicine – there are simply not enough 
cases. This consistent limitation is overlooked by most 
machine learning researchers. However, by using the 
unique technique of interactive machine learning, 
we can reduce the number of datasets required at 
least by a factor of 10 or even more. Therefore, we 
increase our chances of obtaining a reasonable result 
very early on in the study - even with a low number 
of cases - and even after a short period of time, which 
places us in a very promising position within the specific 
area of artificial intelligence. We generate a solid case 
by applying this unique machine learning approach in 
this particular context.
By making the systematic comparison of tissue 
alterations across different organs, we generate 
digital slides and then compare the histologic imaging 
features with medical imaging features, e.g., MRI; one 
of the techniques we use to link virtopsy to digital 
pathology.
This study provides a systematic understanding 
that can distinguish between postmortem inflammation 
infarcted from autolysis, and thereby generates a new 
database for further imaging programs and algorithm 
developments. This is a “machine learning from 
images” study that has a novel scientific approach with 
a practical setup, a strong focus on what to look for, 
and an innovative way to analyze the data.
In most countries, there are inadequacies with 
regards to conducting large-scale programs for this 
type of study. Firstly, for some subjects, pathologists do 
not receive approval from the relatives, and therefore 
they perform fewer autopsies. Secondly, the time 
lapse of consent is approximately one day, resulting in 
performing autopsies with a marked delay after death. 
Thus, it is most advantageous to include additional 
cases that examine a situation more closely related to 
a living body, which allows us to distinguish between 
disease-related alterations and secondary alterations 
(caused by prolonged autolysis periods).
The virtual biobank will facilitate data fusion, 
data mapping, data integration and data sharing on 
four different levels: (1) Macroscopic; (2) Microscopic; 
(3) Medical imaging; and (4) NMR. The virtual biobank 
will consequently be the basis for a fully-fledged and 
powerful machine learning pipeline. We propose to 
include analysis of in vivo and ex vivo brain structural 
changes in a large sample of subjects; adding a novel 
parameter to the study and enabling insight into 
entirely original, previously unknown aspects.
A team with in-depth experience in machine 
learning and knowledge extraction will support 
and help in building the machine learning pipeline 
and novel knowledge extraction tools. In particular, 
the highly needed visualization tools that enable 
the experts to find, e.g., anomalies, similarities, 
dissimilarities in arbitrarily high dimensional data sets. 
These would be otherwise inaccessible to the human 
end user, if following an interactive machine learning 
approach with the doctor-in-the-algorithmic-loop.3,4
Our unique technique is that we propose to 
construct machine learning algorithms that self-learn 
from and make predictions based on the study 
group data stored in our virtual biobank. Imaging 
biomarkers depend on access to biomaterial, and these 
biological features are readily available at many medical 
universities. Some academic hospitals remain very open 
to both traditional and imaging autopsies for clinical 
and academic studies.5,6 The results from the proposed 
virtopsies are highly reproducible and most developed 
countries can facilitate and provide virtopsies.
In most cases, a study of this kind would usually 
require 1-2 years of data collection. However, some 
research groups possess a record of previously existing 
virtopsy data, which can enable them to perform 
machine learning image analysis from the onset. 
This data allows researchers to develop algorithms 
which they then validate, adapt, use and test in the 
autopsy cases which are to be collected during the 
random period of their study.
Initially, they can train the algorithms on existing 
datasets, which are available from previous virtopsy 
studies, improving the likelihood of achieving expected 
results. However, it is critical to include many datasets 
from autopsies performed rapidly (~3 hours) after 
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clinical death to avoid the risk that ultimately the 
algorithms will fail to recognize autolysis, which 
is the most common phenomenon in these cases. 
The time-course advantage is invaluable for the 
validation of this study. Using an “early cohort” in 
the mix can address specific questions that cannot 
be explained by using a “delayed cohort”. Therefore, 
the “early cohort” allows to witness alterations in the 
dead body as early as possible, as well as to follow 
how this has changed over time and recognize how 
features are influenced by autolysis. Subsequently, the 
outcome is having a superimposition of the pre-existing 
disease – be it an inflammation, infarction or tumor. 
This is then superimposed by the effects of autolysis. 
The intention is to avoid making studies on autolysis 
in pathology since the primary aim is to discover the 
underlying disease.
EXPECTED RESULTS AND HYPOTHESIS
The focus and strengths of this study are on 
novel integrative and interactive machine learning 
approaches, which can complement and extend 
current deep learning approaches. We also envision 
helping to solve problems that would occur when 
comparing radiology data with pathology data. 
With this unique opportunity, we can compare and 
contrast the digital pathology with the radiology to 
proceed further in viewing these images; the aspiration 
of many radiologists. We have an advantage in the 
ability to collect tissue from the deceased, as opposed 
to the case of living subjects. Additionally, we can 
access the lungs, the heart and the brain (if needed); 
which is a unique opportunity that drives the imaging 
field in general, not only in the context of virtopsy.
The ability to compare radiology data with 
histology and digital pathology allows us to see how far 
the principles of machine learning image analysis can 
be applied - with different technologies and different 
imaging types. We create a biobanking library of digital 
images together with material data, which makes it 
a compelling resource. These are major factors of the 
core scientific approach that increase the likelihood 
of success.
This virtopsy proposal aims to use autopsies 
while incorporating new technologies - such as 
medical imaging - to improve how infectious diseases 
are examined. This research will help to understand 
the processes of diseases and evaluate both clinical 
diagnosis and treatment. It will enhance understanding 
in respect of therapy resistance by cancer patients 
with minimal tumor burden, and even the cause 
of death in such patients. Essential baseline data 
outcomes will quantify and compare tumor mass in 
cases involving diverse patients (according to their 
metabolic conditions). We hypothesize that virtopsy 
is dramatically more advantageous at mapping 
cardiovascular alterations, hemorrhages, and misuse 
of medical devices.7 As a result of its strong application 
opportunities and high impact, this study is scientifically 
significant and innovative – particularly the substantial 
savings in time and finance, and delivery of rapid 
reliable data and diagnosis:
• Virtopsy provides new possibilities to clarify the 
pathogenesis of specific diseases, particularly those 
which affect organs or clinical conditions that impede 
in vivo tissue sampling. This is predominantly relevant to 
postmortem sampling of selected areas of the brain, that 
shed light on the biology of a variety of mental disorders 
such as dementia, Alzheimer’s disease, schizophrenia 
and depression;
• In the recent episodes of Ebola, portable ultrasound 
imaging may have been applied in remote regions of 
Africa. In addition, this application may have led to a 
faster identification of Zika virus as being the cause of 
microcephaly during the recent outbreak in Brazil. It may 
have reduced the number of Ebola and microcephaly 
cases worldwide;
• In circumstances where corpses are suspected to have 
high-risk pathogens or infectious diseases, imaging 
autopsies will protect medical staff. The innovative 
methods eliminate the risks of contamination associated 
with the use of knives, needles, and scissors in 
conventional procedures;
• Virtopsy also obviates negative outcomes for DNA 
sequencing and pathogen detection, particularly in 
biopsies required for immune testing;
• This project addresses many unanswered questions in 
digital pathology. These relate to the lack of international 
literature on large-scale programs. Such programmes 
that compare MRI data with molecular phenotypes in 
an incisive, coordinated way that is expounded in this 
study;
• Image-guided biopsies have become an important factor 
in reference to the ethics of autopsies. They will detect 
the cause of death in the majority of cases; in doing so 
they improve quality control and diminish the economic 
burden of conventional autopsies;7
• The results from this project are highly reproducible 
in other countries. Medical imaging autopsy is a 
valid alternative method, and it will increase autopsy 
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acceptance rates,7 particularly among cultures that 
oppose autopsies on ethical and/or religious grounds.
In summary,  we plan to combine al l  the 
aforementioned diverse steps of autopsy and data 
analysis. The anticipated result will provide a new 
method of analyzing digital data from virtopsy 
and digital pathology; identifying improvements in 
diagnostic techniques, and assisting physicians with 
finding the correct diagnosis. We are confident that 
the entirety of our multi-faceted approach will provide 
the desired results and advance the state-of-the-art.
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